...
首页> 外文期刊>Journal of Comparative Pathology >Effect of different vaccine formulations on the development of Glasser's disease induced in pigs by experimental Haemophilus parasuis infection.
【24h】

Effect of different vaccine formulations on the development of Glasser's disease induced in pigs by experimental Haemophilus parasuis infection.

机译:不同疫苗制剂对实验性副猪嗜血杆菌感染猪所致格拉瑟氏病的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Four groups of pigs immunized with different vaccines and a group of non-vaccinated controls were challenged intratracheally with a lethal dose (5x109 colony-forming units) of Haemophilus parasuis, the aetiological agent of Glasser's disease. A vaccine containing inactivated whole organisms gave strong protection against clinical signs, death, pathological changes and persistence of organisms in vivo. However, all non-immunized pigs, all pigs given a vaccine consisting of the recombinant transferring-binding protein (Tbp) B, some pigs given an outer membrane protein (OMP) formulation enriched with TbpB and some pigs immunized with a sub-lethal dose of live organisms died at various times after challenge, yielding positive cultures from most organs post mortem and having shown hyperthermia and other clinical signs before death. Animals that died showed fibrinosuppurative polyserositis, exudative pneumonia, and lesions compatible with acute septicaemia, e.g., disseminated intravascular coagulation with multiple fibrinous thrombi in arterioles and capillaries, depletion of splenic white pulp, and acute lymphadenitis. The results suggested that, in addition to the protection given by inactivated whole organisms, partial protection was given by the OMP formulation and by a sub-lethal dose of living organisms; however, the recombinant TbpB preparation gave no protection.
机译:用致死剂量(5x10 9 菌落形成单位)副猪嗜血杆菌的气管内攻击四组用不同疫苗免疫的猪和一组未接种疫苗的对照。格拉瑟氏病的病因。包含灭活的完整生物的疫苗对临床体征,死亡,病理变化和生物在体内的持久性提供了强有力的保护。但是,所有未免疫的猪,所有给猪注射了由重组转移结合蛋白(Tbp)B组成的疫苗,一些给猪提供了富含TbpB的外膜蛋白(OMP)制剂和一些以亚致死剂量免疫的猪的生物体在攻击后的不同时间死亡,死后大部分器官均产生阳性培养物,并在死亡前表现出高温和其他临床体征。死亡的动物表现出纤维化脓性多发性浆膜炎,渗出性肺炎和与急性败血病相容的病变,例如,在小动脉和毛细血管中弥散性血管内凝血和多发性纤维状血栓,脾脏白浆耗竭和急性淋巴结炎。结果表明,除灭活的整个生物体提供的保护外,OMP配方和亚致死剂量的活生物体也提供了部分保护。然而,重组的TbpB制剂没有提供保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号